Although there is growing scientific evidence showing medicinal cannabis can benefit patients in a variety of clinical settings, Little Green Pharma believes further research is still needed.
Little Green Pharma is involved with five clinical investigations that are studying cannabinoid medicines, including our own medicinal cannabis oil products. The data and study outcomes may be used to inform the company’s clinical trials strategy related to the selection of suitable medical indications for drug registration in Australia, the UK and Europe.
To learn more about our current clinical development program activities, visit https://investor.littlegreenpharma.com/site/projects/research-development.
Partner with us
If you are interested in collaborating with Little Green Pharma regarding medical education grants, scholarships or specific investigator-initiated pre-clinical and clinical research, please send site and investigator information to LGP via email.